In recent years, it has been demonstrated that TNF-α represents one crucial element in the development of psoriatic arthritis, and both direct and receptor TNF-α inhibitors are currently utilized as well-tolerated pharmacological treatments [106]. The gene discussed is TNF; the disease is psoriatic arthritis.